June 23, 2017 7:08 PM ET

Pharmaceuticals

Company Overview of AbGenomics Corporation

Company Overview

AbGenomics Corporation engages in the discovery and development of therapeutic antibodies for immune-related inflammatory diseases and cancers. It develops therapeutic antibodies for the treatment of autoimmune diseases, allergy, asthma, transplantation rejection, and cancer. The company’s products include agonistic monoclonal antibodies, humanized monoclonal antibodies, enzyme controlling insulin sensitivity and lipid metabolism, and proteins. It also provides consulting services through its subsidiary. AbGenomics Corporation was founded in 2000 and is based in Taipei, Taiwan. AbGenomics Corporation operates as a subsidiary of AbGenomics International, Inc.

2F, No. 36, Lane. 358

Juikuang Road

Neihu

Taipei,  114

Taiwan

Founded in 2000

Phone:

886 2 2627 2707

Fax:

886 2 2627 2708

Key Executives for AbGenomics Corporation

President and Director of Research & Clinical Development
Chief Operation Officer and Vice President
Senior Director of Preclinical Development
Compensation as of Fiscal Year 2016.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact AbGenomics Corporation, please visit www.abgenomics.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.